New drug forces aggressive leukemia cells to die from stress
Pushing the accelerator and the brake at the same time is rarely a good idea. But researchers at…
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Moleculin Biotech, Inc. Moleculin Biotech, Inc. INTERIM EFFICACY – N=45 INTENT TO TREAT (ITT) Both Annamycin dose arms…
Study finds increasing rates of therapy-related acute myeloid leukemia
Some therapies used to treat cancer may increase the risk of later developing cancers that affect the blood.…